MedPath

INLYTA

INLYTA

Approved
DIN Number

02389649

Drug Class

Human

Market Date

Aug 17, 2012

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02389649
AIG Number0153228002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EK01 AXITINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

AXITINIBActive
Strength: 5 MG
Monograph: AXITINIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.